Shanghai Fosun Pharmaceutical (Group) Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Shanghai Fosun Pharmaceutical (Group) Stock Forecast and Price Target
The average price target of ¥29.15 for Shanghai Fosun Pharmaceutical (Group)'s stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 29.5% from the last closing price in April, 2024 if reached by the end of the year. This potential increase is based on a high estimate of ¥35.00 and a low estimate of ¥24.50. If you're interested in 600196 stock, it's important to compare it to other companies in the industry.
29.50% Upside
Shanghai Fosun Pharmaceutical (Group) Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Shanghai Fosun Pharmaceutical (Group)'s Price has decreased from ¥38.08 to ¥0.00 – a 100.00% drop! In the next year, analysts believe that Fair Value will reach ¥57.83 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MRK Stock Forecast | Merck | Outperform |
2
|
$125.78 | Buy/Sell | $130.51 | 10.51% |
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$48.93 | Buy/Sell | $58.15 | 12.41% |
| 6501 Stock Forecast | Hitachi | Outperform |
4
|
¥13.33k | Buy/Sell | ¥11.29k | 6.53% |
| SHL Stock Forecast | Siemens Healthineers | Buy |
8
|
50.80€ | Buy/Sell | 56.34€ | 18.11% |
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF502.80 | Buy/Sell | CHF516.89 | 16.35% |
Shanghai Fosun Pharmaceutical (Group) Revenue Forecast for 2023 - 2025 - 2030
Shanghai Fosun Pharmaceutical (Group)'s Revenue has seen impressive growth In the last two years, rising from ¥30.31B to ¥43.95B – a growth of 45.02%. In the next year, analysts believe that Revenue will reach ¥48.01B – an increase of 9.23%. For the next seven years, the forecast is for Revenue to grow by 12.27%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600276 Stock Forecast | Jiangsu Hengrui Medicine | Outperform |
15
|
¥41.68 | Buy/Sell | ¥56.49 | 30.76% |
| 7751 Stock Forecast | Canon | Hold |
18
|
¥4.28k | Buy/Sell | ¥3.74k | -11.24% |
| PHIA Stock Forecast | Koninklijke Philips N.V. | Hold |
18
|
18.85€ | Buy/Sell | 19.42€ | 3.45% |
.jpg)
Shanghai Fosun Pharmaceutical (Group) Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Shanghai Fosun Pharmaceutical (Group) has seen a decline in its Dividend per Share, from ¥0.43 to ¥0.42 – a 2.33% decrease. For the next year, analysts predict that Dividend per Share will reach ¥0.46 – an increase of 9.52%. Over the next seven years, experts believe that Shanghai Fosun Pharmaceutical (Group)'s Dividend per Share will grow at a rate of 33.42%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BGNE Stock Forecast | BeiGene | Buy |
6
|
$129.52 | Buy/Sell | $285.19 | 112.32% |
| BDMS Stock Forecast | Bangkok Dusit Medical Services... | Buy |
18
|
฿27.75 | Buy/Sell | ฿33.89 | 26.13% |
| IHH Stock Forecast | IHH Healthcare Berhad | Outperform |
18
|
RM6.12 | Buy/Sell | RM7.00 | 16.83% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| APOLLOHOSP Stock Forecast | Apollo Hospitals Enterprise | Outperform |
18
|
Rp6.17k | Buy/Sell | Rp6.91k | 16.70% |
| CTLT Stock Forecast | Catalent | Hold |
15
|
$55.48 | Buy/Sell | $49.29 | 14.46% |
| 1099 Stock Forecast | Sinopharm Group | Buy |
18
|
HK$19.88 | Buy/Sell | HK$25.81 | 26.86% |
Shanghai Fosun Pharmaceutical (Group) EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Shanghai Fosun Pharmaceutical (Group)'s EBITDA has seen an increase, rising from ¥4.08B to ¥5.54B. This represents a growth of 35.71%. Analysts predict that Shanghai Fosun Pharmaceutical (Group)'s EBITDA will increase in the upcoming year, reaching ¥7.57B. This would represent an increase of 36.54%. Over the next seven years, experts predict that Shanghai Fosun Pharmaceutical (Group)'s EBITDA will grow at a rate of 27.18%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1801 Stock Forecast | Innovent Biologics | Buy |
6
|
HK$33.20 | Buy/Sell | HK$50.60 | 53.01% |
| 601607 Stock Forecast | Shanghai Pharmaceuticals Holdi... | Outperform |
18
|
¥17.79 | Buy/Sell | ¥20.67 | 23.66% |
| RHC Stock Forecast | Ramsay Health Care | Hold |
18
|
$50.09 | Buy/Sell | $56.32 | 11.82% |
Shanghai Fosun Pharmaceutical (Group) EBIT Forecast for 2023 - 2025 - 2030
Shanghai Fosun Pharmaceutical (Group)'s EBIT has seen growth In the last two years, going from ¥2.62B to ¥3.42B – a gain of 30.64% In the next year, analysts believe that EBIT will reach ¥4.50B – an increase of 31.69%. For the next seven years, the forecast is forEBIT to grow by 34.75%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 000999 Stock Forecast | China Resources Sanjiu Medical... | Buy |
18
|
¥59.25 | Buy/Sell | ¥65.95 | 5.99% |
| 874 Stock Forecast | Guangzhou Baiyunshan Pharmaceu... | Outperform |
16
|
HK$20.35 | Buy/Sell | HK$24.33 | 11.94% |
| BH Stock Forecast | Bumrungrad Hospital Public Com... | Outperform |
18
|
฿224.00 | Buy/Sell | ฿132.75 | 27.23% |
Shanghai Fosun Pharmaceutical (Group) EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Shanghai Fosun Pharmaceutical (Group)'s EPS has decreased from ¥1.06 to ¥0.00 – a 100.00% drop! In the next year, analysts believe that EPS will reach ¥1.61 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 9926 Stock Forecast | Akeso | Buy |
4
|
HK$43.90 | Buy/Sell | HK$49.90 | 25.58% |
| 600079 Stock Forecast | Humanwell Healthcare (Group) | Buy |
0
|
¥19.61 | Buy/Sell | ¥32.49 | -100.00% |
| 000513 Stock Forecast | Livzon Pharmaceutical Group | Outperform |
18
|
¥36.98 | Buy/Sell | ¥39.23 | 11.41% |
Site Navigation
.jpg)